Production of a food commodity is based on the supply of juveniles.
Terrestrial livestock production has well-established and precise mechanisms
for insuring that the supply of stock is perpetual; the growing cycle is
continuous. The fundament of this production is a breeding and broodstock
programme that insures the continual supply of seed to growout operations.
In aquaculture, breeding programmes are, for the most part, in their infancy
by comparison to terrestrial production. These salmon breeding programmes
are in large measure based upon programmes developed for swine and poultry.
As salmon breeding programmes are comparatively new, there are great gains
realized in short times owing to the limited selective pressure on various
traits. Often, these genetic gains are 10-15% per breeding generation.
Here
the similarities between terrestrial and aquatic breeding programmes begin
to disappear. Where terrestrial systems are perpetual, salmon seed
production is largely cyclical. Indeed, with few exceptions, most salmon
spawning still occurs in the autumn. Further, while terrestrial systems have
on-demand propagation, salmon reproduction is largely at the mercy of
natural cycles. Lest not to seem doom and gloom, there have been significant
advances in salmon production and seed supply.
One of the most productive mechanisms to perpetuate seed supply is
photoperiod and temperature manipulation. In some stocks, the breeding
season is extended, or put out of season by strictly controlled photoperiod
regimes. Temperature control serves to preserve egg quality while
compressing and advancing spawning times. However, these facilities are very
specialized and few in number. The vast majority of salmon ova supply still
comes from net cage operations.
While photoperiod and temperature manipulation can delay or advance the
spawning season, the problem of asynchronous spawning remains. That is, as
one fish matures, it may not be spawning the same time as her cohorts. This
can mean delays further down the production line as there may not be enough
ova from early or late spawning fish to fill a production lot. As well,
males are notorious at being early, late or spent when females are ready.
One solution to answering the asynchrony issue was developed in the 1930’s.
Researchers took pituitaries from ripe fish and fed, implanted or injected
them into later-spawning fish. This practice was carried over to Indian carp
until very recently and is called hypophysation. The idea here is to take
the residual and indigenous gonadotropins in the pituitary of one fish and
augment those of the soon to be spawner. More recently, carp pituitaries or
their extract is administered to other species of fish to induce them to
spawn. This can work well for carp, but requires larger doses for other
species. Further, there are concerns about immunogenesis or the development
of an immune response in repeated use, doses and efficacy in new species. To
many, CPE is still the standard. The human equivalent to CPE is human
chorionic gonadotropin or HCG. It is available in purified form, but the
issues of dose, immunogenesis, and having to increase dose with increase use
persist.
In mammals, the endocrine cascade of reproductive hormones was well
described in the early part of the twentieth century. Likewise, the tools to
induce ovulation in cattle, swine and horses were developed early on.
However, fish reproductive systems evaded scientific investigation for some
time. In fact, the identification of the brain
(hypothalamus)-pituitary-gonadal axis was not recognized and accepted until
the late 1980’s or early 1990’s. While the brain peptide that controls
reproduction in mammals, LHRH, was identified in 1972; the fish counterpart
was not identified until 1984.
Once the controlling mechanism for fish was equated with mammals, research
into induced maturation matured. This was supported by crossover work done
on LHRH and it’s analogues for use in human pharmaceuticals. The first
wide-scale use of brain peptide analogues (GnRHa) was directed at carp
because of the history of hypophysation. It was soon elucidated that GnRHa
alone was not enough to induce spawning, but that another brain chemical,
dopamine, had to be inhibited before spawning could be induced. From this,
the product Ovaprim was developed and has been used to great success for
over 15 years. Indeed, the induction of maturation in Indian carps by
Ovaprim has been accepted as standard procedure and has permitted the
expansion of the carp industry in India.
Further studies on the induction of spawning in food fish, primarily salmon
showed that sustained-release preparations of GnRHa had superior results
over single bolus injections. This work capitalized on the aspirations of
researchers to unlock the intricacies of the HPG axis in fish coupled to the
need of the salmon aquaculture industry to secure seed stocks. These
sustained-release preparations served to continually stimulate the natural
endocrine cascade in maturing fish to coordinate and synchronize spawning
times in large groups of salmon. At first bulky and awkward to use, more
practical and user-friendly forms soon evolved.
By the mid 1990’s, sustained-release preparations of the most potent salmon
GnRH analogues were released from testing to the marketplace. By 1998,
Ovaplant, a sustained-release implant containing sGnRHa was tested and
approved for use in Chile. Ovaplant was soon demonstrated to be a cost
effective method of advancing and synchronizing spawning dates in either
seawater or freshwater-held broodstock salmon. Further, the issue of milt
supply was obviated as milt production was assured and milt volumes
increased. This assurance of milt supply has had an added economic benefit
to producers in that fewer males are wasted due to non-productivity simply
by using the implant.
In photoperiod-controlled spawners, Ovaplant proved effective at
synchronizing spawning dates without appreciably sacrificing egg quality.
This method of induced maturation has spread from salmon to other species of
interest in aquaculture. Halibut producers now routinely use Ovaplant to
keep males running through the long spawning cycle. It has also found a
niche in preserving the gene pool among threatened or endangered species.
Ovaplant is currently being tested in field trials in Canada and Ireland.
These field trials will form part of the requirements for full drug
registration in those jurisdictions.
While salmon producers on a permanent scale have not secured a continuous
production of seed, there have been great gains in technological
development. With the tools of photoperiod and temperature manipulation,
breeding programmes and induced maturation, producers are making progress
towards the goal of year-round egg supply within companies. While the idea
of a breeder facility for salmon may seem far-fetched, it is clearly
possible.